US Stock MarketDetailed Quotes
LSDI Lucy Scientific Discovery
- 1.170
- +0.030+2.63%
Trading Apr 16 10:06 ET
2.06MMarket Cap-182P/E (TTM)
1.180High1.170Low1.84KVolume1.140Open1.140Pre Close2.17KTurnover0.16%Turnover RatioLossP/E (Static)1.76MShares17.00052wk High25.43P/B1.35MFloat Cap1.05052wk Low--Dividend TTM1.15MShs Float40.000Historical High--Div YieldTTM0.88%Amplitude1.050Historical Low1.176Avg Price1Lot Size
About Lucy Scientific Discovery Company
Lucy Scientific Discovery, Inc. is an early-stage company, which engages in the manufacture of psychotropics contracts. It focuses on the research, development, and manufacture of psychotropics-based medicines. Its products include raw materials, crude extracts, targeted formulations, white and private label products, and single molecule fractions. The company was founded on February 17, 2017 and is headquartered in Victoria, Canada.
Company Profile
SymbolLSDI
Company NameLucy Scientific Discovery
Listing DateFeb 9, 2023
Issue Price4.00
Founded2017
CEOMr. Richard D Nanula
MarketNASDAQ
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address1321 Blanshard Street,Suite 301
CityVictoria
ProvinceBritish Columbia
CountryCanada
Zip CodeV8W 0B6
Phone1-778-410-5195
Company Executives
- Name
- Position
- Salary
- Richard D Nanula
- Executive Chairman of the Board and Chief Executive Officer
- 41.67K
- Brian Zasitko, C.A.,C.P.A.
- Chief Financial Officer and Principal Accounting Officer
- 100.00K
- Dr. Assad J. Kazeminy, PhD
- Chief Scientific Officer
- 180.00K
- Scott M. Reeves
- Director and Corporate Secretary
- --
- Charles B. Nemeroff,M.D.,PhD
- Independent Director
- --
- Brittany Kaiser
- Independent Director
- --
- Paul Abramowitz
- Independent Director
- --
- Livio Susin
- Independent Director
- 92.15K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg